Kruger, B.; Chimusa, E.R.; Abera, A.B.; Singh, J.; Shamley, D.; Dandara, C.
Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen. J. Pers. Med. 2026, 16, 188.
https://doi.org/10.3390/jpm16040188
AMA Style
Kruger B, Chimusa ER, Abera AB, Singh J, Shamley D, Dandara C.
Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen. Journal of Personalized Medicine. 2026; 16(4):188.
https://doi.org/10.3390/jpm16040188
Chicago/Turabian Style
Kruger, Bianca, Emile R. Chimusa, Aron B. Abera, Jesmika Singh, Delva Shamley, and Collet Dandara.
2026. "Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen" Journal of Personalized Medicine 16, no. 4: 188.
https://doi.org/10.3390/jpm16040188
APA Style
Kruger, B., Chimusa, E. R., Abera, A. B., Singh, J., Shamley, D., & Dandara, C.
(2026). Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen. Journal of Personalized Medicine, 16(4), 188.
https://doi.org/10.3390/jpm16040188